QGEN
Qiagen NV
NYSE: QGEN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$42.50
+0.88% today
Updated 2026-09-11
Market cap
$8.75B
P/E ratio
21.51
P/S ratio
4.17x
EPS (TTM)
$1.97
Dividend yield
0.84%
52W range
$31 – $54
Volume
2.9M
Qiagen NV (QGEN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$42.50
12-Month target
$39.87
2030 Target
—
Intrinsic (DCF)
$40.16
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.3B | $2.1B | $2.0B | $2.0B | $2.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 21.51x (capped 25x) · Margin: 19.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.